1. Chou R, Ballantyne J, Lembke A. Rethinking opioid dose tapering, prescription opioid
dependence, and indications for buprenorphine. Ann Intern Med. 2019; 171: 427-9.[PMID …

Background The State of New York, along with the whole nation, is struggling to combat the
opioid epidemic. Major authoritative bodies on chronic pain and addiction have advocated …

A 48 year old male with a distant history of heroin use disorder presents to the emergency
department with a right distal humerus fracture after falling from a ladder at work. He has …

Background: Suboxone (buprenorphine-naloxone combination drug) is prescribed for opioid
use disorders (OUD) treatment. Naloxone (in suboxone) acts an antagonist to dissuade drug …

Créé en 1964, l'Institut National de la Santé et de la Recherche Médicale (Inserm) est un
établissement public à caractère scientifique et technologique sous la tutelle du ministère de …

August 2018• Volume 127• Number 2 www. anesthesia-analgesia. org 337 aim to address
whether buprenorphine is indeed safer than potential alternatives. Because serious adverse …

Suboxone®(buprenorphine/naloxone) is approved by the US Food and Drug Administration
(FDA) for opioid maintenance therapy. 1, 2 The purpose of this article is to provide dentists …

Chronic pain is a major public health problem worldwide that is highly prevalent. Among the
available pharmacological treatments, opioids are widely used to treat moderate-to-severe …

The opioid crisis has disproportionately impacted rural areas such as eastern North
Carolina. Buprenorphine is an evidenced-based treatment for individuals experiencing …

This case report demonstrates using buprenorphine 32 mg to achieve adequate pain control
after a total knee replacement. The patient stopped buprenorphine 48 hours before surgery …